Palmitoyl Tripeptide-1 (Pal-GHK)
Palmitoyl Tripeptide-1 is a lipopeptide fragment of collagen that stimulates collagen I, III, and fibronectin synthesis through TGF-β pathway activation. It is a key component of the Matrixyl 3000 complex.
Palmitoyl Tripeptide-1 is a palmitoylated derivative of the GHK (glycyl-L-histidyl-L-lysine) peptide fragment, classified as a signal peptide in cosmetic science. By mimicking collagen breakdown products, it signals fibroblasts to synthesize new extracellular matrix components.
Overview
Palmitoyl Tripeptide-1 belongs to the class of matrikine peptides -- small peptide fragments released during extracellular matrix turnover that regulate cell activities including proliferation, migration, and matrix synthesis. The palmitoyl (C16 fatty acid) moiety is attached to enhance lipophilicity and improve penetration through the stratum corneum.
The peptide is a core component of Matrixyl 3000, a proprietary complex developed by Sederma that combines Pal-Tripeptide-1 with Palmitoyl Tetrapeptide-7. While Pal-Tripeptide-1 drives collagen neosynthesis, the tetrapeptide-7 component reduces inflammatory cytokine production (particularly IL-6), providing a dual mechanism that addresses both matrix degradation and chronic low-grade inflammation associated with skin aging.
Mechanism of Action
Palmitoyl Tripeptide-1 functions as a signal peptide that mimics the small peptide fragments generated during collagen degradation. When collagen is broken down by matrix metalloproteinases (MMPs), the resulting fragments act as positive-feedback signals to fibroblasts, prompting new collagen synthesis. Pal-Tripeptide-1 replicates this signaling cascade.
The primary pathway involves activation of TGF-β (transforming growth factor beta) signaling. Upon binding to fibroblast receptors, the peptide upregulates TGF-β production, which in turn activates Smad-dependent transcription of procollagen genes. This leads to increased synthesis of:
- Collagen type I -- the predominant structural collagen in dermis
- Collagen type III -- important for skin elasticity and wound repair
- Fibronectin -- a glycoprotein critical for cell adhesion and ECM organization
The palmitoyl chain facilitates membrane interaction and cellular uptake, improving bioavailability at the dermal-epidermal junction compared to unmodified GHK.
Additionally, Pal-Tripeptide-1 has been shown to upregulate hyaluronic acid synthase expression, contributing to improved dermal hydration and plumping effects that complement its structural collagen benefits. The peptide also modulates MMP expression, reducing enzymatic degradation of existing collagen while simultaneously promoting new synthesis -- a dual mechanism that accelerates net collagen accumulation.
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Collagen Stimulation
In vitro studies using human dermal fibroblast cultures demonstrate that Palmitoyl Tripeptide-1 stimulates collagen synthesis in a dose-dependent manner. Lintner et al. (2009) reported significant upregulation of procollagen I and III production, with concomitant increases in fibronectin and glycosaminoglycan synthesis. The effect was comparable to or greater than that of retinol at equivalent concentrations in certain assay conditions.
Matrixyl 3000 Clinical Data
Clinical evaluation of Matrixyl 3000 (Pal-Tripeptide-1 + Pal-Tetrapeptide-7) applied at 3% concentration twice daily for 56 days demonstrated measurable improvements in wrinkle depth, skin firmness, and overall skin texture. Robinson et al. (2005) documented wrinkle volume reduction and improvements in skin roughness parameters using profilometric analysis.
Comparison with Parent Peptide GHK
The native GHK tripeptide has well-documented wound-healing and collagen-stimulating properties. Pickart et al. (2015) characterized GHK as a broad-spectrum regenerative signal capable of modulating over 4,000 genes. Palmitoylation enhances skin penetration without significantly altering the binding affinity for target receptors. Studies comparing Pal-GHK to unmodified GHK show improved dermal delivery and sustained activity when formulated in emulsion systems.
Formulation Considerations
Palmitoyl Tripeptide-1 is typically supplied as a pre-dissolved concentrate for incorporation into cosmetic formulations. The palmitoyl chain provides good compatibility with oil-in-water emulsion systems, which are the preferred vehicle type. The peptide is stable at pH 5.0-6.5 and should be added to formulations below 40C to prevent thermal degradation. When formulated as part of Matrixyl 3000, the two peptide components are pre-blended at optimized ratios by Sederma.
Recommended use levels are typically 2-4% of the commercial solution in finished products. The peptide is compatible with most cosmetic preservative systems and can be combined with other anti-aging actives including retinoids, vitamin C derivatives, and hyaluronic acid without stability concerns.
Safety Profile
Palmitoyl Tripeptide-1 has an excellent safety profile in topical applications. No significant adverse reactions have been reported in clinical studies at concentrations up to 5%. Dermal irritation and sensitization testing demonstrate minimal potential for allergic contact dermatitis. The peptide does not exhibit phototoxicity or mutagenicity in standard safety assays. As a naturally occurring peptide fragment with a lipid modification, it is generally regarded as safe for cosmetic use by regulatory authorities including the EU Scientific Committee on Consumer Safety. Long-term use studies spanning 12 months of daily application have confirmed sustained safety with no cumulative adverse effects.
Pharmacokinetic Profile
Quick Start
- Route
- Topical (serum, cream)
Research Protocols
topical
Safety Profile Palmitoyl Tripeptide-1 has an excellent safety profile in topical applications.
| Goal | Dose | Frequency | Duration |
|---|---|---|---|
| General Research Protocol | See literature | Twice daily | 12 months(Route: Topical) |
Interactions
Peptide Interactions
The native GHK tripeptide has well-documented wound-healing and collagen-stimulating properties. Pickart et al. (2015) characterized GHK as a broad-spectrum regenerative signal capable of modulating over 4,000 genes. Palmitoylation enhances skin penetration without significantly altering the bind...
What to Expect
What to Expect
Clinical evaluation of Matrixyl 3000 (Pal-Tripeptide-1 + Pal-Tetrapeptide-7) applied at 3% concentration twice daily for 56 days demonstrated...
Long-term use studies spanning 12 months of daily application have confirmed sustained safety with no cumulative adverse effects.
Continued use as directed
Quality Indicators
What to look for
- Naturally occurring compound
Frequently Asked Questions
References (4)
- [5]
- [1]Robinson LR et al Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin Int J Cosmet Sci (2005)
- [4]Pickart L et al GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration BioMed Res Int (2015)
- [2]Lintner K et al Cosmetic peptides Int J Cosmet Sci (2009)
Palmitoyl Hexapeptide-12
Palmitoyl Hexapeptide-12 (Biopeptide EL) is a Sederma-developed lipopeptide that stimulates elastin synthesis in dermal fibroblasts, researched for improving skin firmness and elasticity in anti-aging applications.
Palmitoyl Tripeptide-38
Palmitoyl Tripeptide-38 (MATRIXYL synthe'6) is a synthetic signal peptide developed by Sederma that stimulates production of six major extracellular matrix proteins, researched for its comprehensive anti-aging and skin-restructuring properties.